HP - Helmerich & Payne, Inc.
NYSE
->
Energy
->
Oil & Gas Drilling
Tulsa,
United States
Type: Equity
HP price evolution
HP
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $282 | $262.18 | $279.24 | |
| Short term investments | $86.09 | $83.39 | $84.12 | |
| Net receivables | $418.6 | $415.39 | $431.68 | $435.82 |
| Inventory | $117.88 | $115.31 | $107.21 | $101.42 |
| Total current assets | $1192.07 | $970.32 | $948.78 | $988.68 |
| Long term investments | $292.23 | $274.45 | $263.44 | |
| Property, plant & equipment | $3083.35 | $3071.66 | $3053.55 | $3032.63 |
| Goodwill & intangible assets | $101.41 | $103.01 | $104.62 | |
| Total noncurrent assets | $3514.66 | $3476.07 | $3432.65 | |
| Total investments | $378.32 | $357.84 | $347.56 | |
| Total assets | $5781.9 | $4484.98 | $4424.85 | $4421.33 |
| Current liabilities | ||||
| Accounts payable | $135.08 | $158.9 | $158.3 | $157.3 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $446.95 | $456.79 | $438.84 | $468.99 |
| Long term debt | $1782.18 | $545.59 | $545.44 | $545.29 |
| Total noncurrent liabilities | $1171.35 | $1182.94 | $1192.7 | |
| Total debt | $545.59 | $545.44 | $545.29 | |
| Total liabilities | $2864.75 | $1628.14 | $1621.77 | $1661.68 |
| Shareholders' equity | ||||
| Retained earnings | $2883.59 | $2833.14 | $2786.49 | $2743.79 |
| Other shareholder equity | -$6.35 | -$8.5 | -$7.71 | -$7.85 |
| Total shareholder equity | $2856.84 | $2803.07 | $2759.65 | |
| (in millions $) | 30 Oct 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $316.24 | $268.38 | $917.53 | |
| Short term investments | $93.6 | $117.1 | $198.7 | |
| Net receivables | $418.6 | $404.19 | $458.71 | $228.89 |
| Inventory | $117.88 | $94.23 | $87.96 | $84.06 |
| Total current assets | $1192.07 | $1006.63 | $1002.94 | $1586.57 |
| Long term investments | $264.95 | $218.98 | $135.44 | |
| Property, plant & equipment | $3083.35 | $2972.09 | $2999.87 | $3176.47 |
| Goodwill & intangible assets | $106.23 | $112.81 | $119.49 | |
| Total noncurrent assets | $3375.33 | $3352.59 | $3447.56 | |
| Total investments | $358.55 | $336.08 | $334.14 | |
| Total assets | $5781.9 | $4381.96 | $4355.53 | $5034.13 |
| Current liabilities | ||||
| Accounts payable | $135.08 | $130.85 | $126.97 | $72 |
| Deferred revenue | ||||
| Short long term debt | $483.49 | |||
| Total current liabilities | $446.95 | $418.93 | $394.81 | $866.31 |
| Long term debt | $1782.18 | $545.14 | $542.61 | $542 |
| Total noncurrent liabilities | $1191.08 | $1195.25 | $1255.2 | |
| Total debt | $545.14 | $542.61 | $1025.48 | |
| Total liabilities | $2864.75 | $1610.01 | $1590.06 | $2121.51 |
| Shareholders' equity | ||||
| Retained earnings | $2883.59 | $2707.72 | $2473.57 | $2573.38 |
| Other shareholder equity | -$6.35 | -$7.98 | -$12.07 | -$20.24 |
| Total shareholder equity | $2771.94 | $2765.47 | $2912.62 | |
| (in millions $) | 31 Jan 2025 | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $697.72 | $687.94 | ||
| Cost of revenue | $417.03 | $401.85 | ||
| Gross Profit | $280.7 | $286.09 | ||
| Operating activities | ||||
| Research & development | $10.55 | $12.94 | ||
| Selling, general & administrative | $66.87 | $62.04 | ||
| Total operating expenses | $169.38 | $175.52 | ||
| Operating income | $111.31 | $110.57 | ||
| Income from continuing operations | ||||
| EBIT | $126.72 | $121.29 | ||
| Income tax expense | $33.7 | $32.19 | ||
| Interest expense | $4.34 | $4.26 | ||
| Net income | ||||
| Net income | $88.69 | $84.83 | ||
| Income (for common shares) | $88.69 | $84.83 | ||
| (in millions $) | 30 Oct 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2756.61 | $2872.42 | $2058.94 | $1218.57 |
| Cost of revenue | $1715.1 | $1426.59 | $952.6 | |
| Gross Profit | $1127.4 | $1157.32 | $632.36 | $265.97 |
| Operating activities | ||||
| Research & development | $30.05 | $26.56 | $21.72 | |
| Selling, general & administrative | $206.66 | $182.37 | $172.19 | |
| Total operating expenses | $676.69 | $595.43 | $587.06 | $694.52 |
| Operating income | $561.89 | $45.29 | -$428.55 | |
| Income from continuing operations | ||||
| EBIT | $610.66 | $50.52 | -$405.92 | |
| Income tax expense | $136.85 | $159.28 | $24.37 | -$103.72 |
| Interest expense | $20.53 | $17.28 | $19.2 | $23.95 |
| Net income | ||||
| Net income | $339.44 | $434.1 | $6.95 | -$326.15 |
| Income (for common shares) | $434.1 | $6.95 | -$326.15 | |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $88.69 | $84.83 | $95.17 | |
| Operating activities | ||||
| Depreciation | $97.82 | $104.55 | $93.99 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $7.68 | $8.43 | $7.67 | |
| Total cash flows from operations | $197.39 | $143.72 | $174.8 | |
| Investing activities | ||||
| Capital expenditures | -$134.38 | -$118.3 | -$136.41 | |
| Investments | -$9.94 | -$7.05 | $11.41 | |
| Total cash flows from investing | -$458.75 | -$129.53 | -$111.41 | -$113.07 |
| Financing activities | ||||
| Dividends paid | -$168.46 | -$42.05 | -$42.08 | -$42.29 |
| Sale and purchase of stock | -$3.94 | -$47.36 | ||
| Net borrowings | ||||
| Total cash flows from financing | $986.51 | -$48.05 | -$49.37 | -$98.73 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $1212.42 | $19.82 | -$17.06 | -$37 |
| (in millions $) | 30 Oct 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | $434.1 | $6.95 | -$326.15 | |
| Operating activities | ||||
| Depreciation | $382.31 | $403.17 | $419.73 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $32.46 | $28.03 | $27.86 | |
| Total cash flows from operations | $833.68 | $233.91 | $136.44 | |
| Investing activities | ||||
| Capital expenditures | -$395.46 | -$272.54 | $4.38 | |
| Investments | -$6.43 | $50.42 | -$209.88 | |
| Total cash flows from investing | -$458.75 | -$322.58 | -$167.31 | -$161.99 |
| Financing activities | ||||
| Dividends paid | -$168.46 | -$201.46 | -$107.39 | -$109.13 |
| Sale and purchase of stock | -$247.21 | -$77 | ||
| Net borrowings | -$543.57 | $544.78 | ||
| Total cash flows from financing | $986.51 | -$463.87 | -$734.3 | $425.52 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $1212.42 | $47.23 | -$667.71 | $399.97 |
News
|
A Buffett Buy, a Biotech IPO, and Other Big Insider Buying
247wallst.com
16 Feb 2025
|
|
Belgacem Chariag Bought 217% More Shares In Helmerich & Payne
Simply Wall St. · via Yahoo Finance
13 Feb 2025
|
|
Journal Record Index: Wall Street slumps on inflation worries
The Journal Record Publishing
10 Feb 2025
|
|
Helmerich & Payne Q1 Earnings Surpass Estimates, Revenues Lag
Zacks
10 Feb 2025
|
|
Helmerich & Payne to Post Q1 Earnings: Here's What to Expect
Zacks · via Yahoo Finance
29 Jan 2025
|
|
Helmerich & Payne, Inc.'s (NYSE:HP) Fundamentals Look Pretty Strong: Could The...
Simply Wall St. · via Yahoo Finance
3 Jan 2025
|
|
Baby celebrates 1st birthday after undergoing heart transplant
ABC News
18 Dec 2024
|
|
Helmerich & Payne Down 10% in a Year: What Awaits the Stock?
Zacks · via Yahoo Finance
16 Dec 2024
|
|
Businesses that opened and closed this year in Tulsa. A look at some of the...
Tulsa World
14 Dec 2024
|
|
Why Is Helmerich & Payne (HP) Down 0.3% Since Last Earnings Report?
Zacks · via Yahoo Finance
13 Dec 2024
|
Fundamentals
| Market cap | $2.95B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 98.76M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.67 |
| Quick ratio | 2.40 |